Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: GASTROINTESTINAL MICROBIOME - , . Treffer: 12

2018

Gorkiewicz, G; Moschen, A Gut microbiome: a new player in gastrointestinal disease.
Virchows Arch. 2018; 472(1):159-172 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kump, P; Wurm, P; Gröchenig, HP; Wenzl, H; Petritsch, W; Halwachs, B; Wagner, M; Stadlbauer, V; Eherer, A; Hoffmann, KM; Deutschmann, A; Reicht, G; Reiter, L; Slawitsch, P; Gorkiewicz, G; Högenauer, C The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
Aliment Pharmacol Ther. 2018; 47(1):67-77 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moissl-Eichinger, C; Pausan, M; Taffner, J; Berg, G; Bang, C; Schmitz, RA Archaea Are Interactive Components of Complex Microbiomes.
Trends Microbiol. 2018; 26(1):70-85
Web of Science PubMed FullText FullText_MUG

 

2017

Castellani, C; Singer, G; Kaiser, M; Kaiser, T; Huang, J; Sperl, D; Kashofer, K; Fauler, G; Guertl-Lackner, B; Höfler, G; Till, H Neuroblastoma causes alterations of the intestinal microbiome, gut hormones, inflammatory cytokines, and bile acid composition.
Pediatr Blood Cancer. 2017; 64(8):
Web of Science PubMed FullText FullText_MUG

 

König, J; Siebenhaar, A; Högenauer, C; Arkkila, P; Nieuwdorp, M; Norén, T; Ponsioen, CY; Rosien, U; Rossen, NG; Satokari, R; Stallmach, A; de Vos, W; Keller, J; Brummer, RJ Consensus report: faecal microbiota transfer - clinical applications and procedures.
Aliment Pharmacol Ther. 2017; 45(2):222-239 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lindheim, L; Bashir, M; Münzker, J; Trummer, C; Zachhuber, V; Leber, B; Horvath, A; Pieber, TR; Gorkiewicz, G; Stadlbauer, V; Obermayer-Pietsch, B Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
PLoS One. 2017; 12(1):e0168390-e0168390 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Durchschein, F; Petritsch, W; Hammer, HF Diet therapy for inflammatory bowel diseases: The established and the new.
World J Gastroenterol. 2016; 22(7):2179-2194 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hartmann, P; Seebauer, CT; Mazagova, M; Horvath, A; Wang, L; Llorente, C; Varki, NM; Brandl, K; Ho, SB; Schnabl, B Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.
Am J Physiol Gastrointest Liver Physiol. 2016; 310(5):G310-G322 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kump, P; Högenauer, C Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Dig Dis. 2016; 34 Suppl 1(4):74-81
Web of Science PubMed FullText FullText_MUG

 

2015

Scheperjans, F; Aho, V; Pereira, PA; Koskinen, K; Paulin, L; Pekkonen, E; Haapaniemi, E; Kaakkola, S; Eerola-Rautio, J; Pohja, M; Kinnunen, E; Murros, K; Auvinen, P Gut microbiota are related to Parkinson's disease and clinical phenotype.
Mov Disord. 2015; 30(3): 350-358.
Web of Science PubMed FullText FullText_MUG

 

Stadlbauer, V; Leber, B; Lemesch, S; Trajanoski, S; Bashir, M; Horvath, A; Tawdrous, M; Stojakovic, T; Fauler, G; Fickert, P; Högenauer, C; Klymiuk, I; Stiegler, P; Lamprecht, M; Pieber, TR; Tripolt, NJ; Sourij, H Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.
PLoS One. 2015; 10(10):e0141399-e0141399 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tripolt, NJ; Leber, B; Triebl, A; Köfeler, H; Stadlbauer, V; Sourij, H Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
Atherosclerosis. 2015; 242(1):141-144
Web of Science PubMed FullText FullText_MUG

 

© Meduni Graz Impressum